Cargando…
Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium
Breast cancer risk factors and clinical outcomes vary by tumour marker expression. However, individual studies often lack the power required to assess these relationships, and large‐scale analyses are limited by the need for high throughput, standardized scoring methods. To address these limitations...
Ejemplares similares
-
High‐throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium
por: Abubakar, Mustapha, et al.
Publicado: (2016) -
Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis
por: Sobral-Leite, Marcelo, et al.
Publicado: (2015) -
Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers
por: Sung, Hyuna, et al.
Publicado: (2016) -
Transcription factors zeb1, twist and snai1 in breast carcinoma
por: Soini, Ylermi, et al.
Publicado: (2011) -
Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients
por: Schmidt, Marjanka K, et al.
Publicado: (2009)